Phytochemical analysis and antidiabetic potential of Elaeagnus umbellata (Thunb.) in streptozotocin-induced diabetic rats: pharmacological and computational approach

Table 1 Experimental design and various tretament groups used in the study

Group	Group Category	Treatment given	Route
Group I	Normal control	Normal saline 8 mL/kg	p.o.
Group II	Diabetic control	STZ (50 mg/kg)	i.p.
Group III	Positive control	Glibenclamide 0.5 mg/kg	p.o
Group IV	Me-Ext	100 mg/kg	p.o
Group V	Me-Ext	200 mg/kg	p.o
Group VI	Chf-Ext	100 mg/kg	p.o
Group VII	Chf-Ext	200 mg/kg	p.o
Group VIII	EtAc-Ext	100 mg/kg	p.o
Group IX	EtAc-Ext	200 mg/kg	p.o

Me-Ext Methanolic extract, Chf-Ext Chloroform extract fraction, EtAc-Ext Ethyl acetate extract fraction, STZ Streptozotocin, p.o. Per oral, i.p. Intraperitoneal

ISSN: 2662-7671